Results 101 to 110 of about 766 (143)

Circadian clock genes and insomnia: molecular mechanisms and therapeutic implications. [PDF]

Ann Med
Ren Q, Gu M, Fan X.
europepmc   +1 more source

The Circadian Clock Component REV-ERB Is an Analgesic Target for Cancer-Induced Tactile Pain Hypersensitivity. [PDF]

J Neurosci
Yasukochi S, Yamakawa W, Taniguchi M, Itoyama S, Tsuruta A, Kusunose N, Yamauchi T, Nakamura R, Matsunaga N, Ohdo S, Koyanagi S.   +10 more
europepmc   +1 more source

Transient hypoxia followed by progressive reoxygenation is required for muscle repair. [PDF]

EMBO Rep
Quétin M, Der Vartanian A, Dubois C, Berthier J, Ledoux M, Michineau S, Drayton-Libotte B, Prola A, Sotiropoulos A, Relaix F, Gervais M.   +10 more
europepmc   +1 more source

Chronic administration of SR9009 represses orexinergic transcription.

, 2016
Amador Ariadna, Wang Yongjun, Banerjee Subhashis, M. Theodore, A. SoltLaura, P. BurrisThomas   +5 more
semanticscholar   +1 more source

Rhythms of risk: the intersection of clocks, cancer, and chronotherapy. [PDF]

J Clin Invest
Mello RM, Masri S, Lamia KA.
europepmc   +1 more source

Multi-Omics Landscape of Circadian Clock Dysregulation Across the Chronic Liver Disease Spectrum. [PDF]

Int J Mol Sci
Tong S, Chen W, Chen J, Zhu X, Shi A.
europepmc   +1 more source

Targeting the liver clock improves fibrosis by restoring TGF-β signaling. [PDF]

J Hepatol
Crouchet E, Dachraoui M, Jühling F, Roehlen N, Oudot MA, Durand SC, Ponsolles C, Gadenne C, Meiss-Heydmann L, Moehlin J, Martin R, Brignon N, Del Zompo F, Teraoka Y, Aikata H, Abe-Chayama H, Chayama K, Saviano A, Heide D, Onea M, Geyer L, Wolf T, Felli E, Pessaux P, Heikenwälder M, Chambon P, Schuster C, Lupberger J, Mukherji A, Baumert TF.   +29 more
europepmc   +1 more source

Circadian rhythm disruption modulates enteric neural precursor cells differentiation leading to gastrointestinal motility dysfunction via the NR1D1/NF-κB axis. [PDF]

J Transl Med
Zhang Y, Xu S, Fan M, Yao H, Jiang C, He Q, Shi H, Lin R.   +7 more
europepmc   +1 more source

Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma. [PDF]

J Clin Invest
Liu Y, Wu J, Najem H, Lin Y, Pang L, Khan F, Zhou F, Ali H, Heimberger AB, Chen P.   +9 more
europepmc   +1 more source

New biochemical approaches for the treatment of glioblastoma. [PDF]

J Biol Chem
Lindsey-Boltz LA, Sancar A.
europepmc   +1 more source